Impact Biomedical Quote - IBO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.57

Bid

Ask

Volume

18,726

1.53 Day's Range 1.8795

1.16 52 Week Range 3.25

Previous Close

1.61

Open

1.69

Last Trade

1.51

Last Trade Time

11:42:12

Average Volume (3m)

45,519

Financial Volume

US$ 30,748

VWAP

1.642

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

Form 8-K - Current report

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.21	-11.797752809	1.78	1.8795	1.5001	9081	1.66567366	CS
4	-0.05	-3.08641975309	1.62	2.16	1.16	25346	1.55219658	CS
12	-0.32	-16.9312169312	1.89	3.25	1.16	45519	2.30373418	CS
26	-1.43	-47.6666666667	3	3.25	1.16	69930	2.22468201	CS
52	-1.43	-47.6666666667	3	3.25	1.16	69930	2.22468201	CS
156	-1.43	-47.6666666667	3	3.25	1.16	69930	2.22468201	CS
260	-1.43	-47.6666666667	3	3.25	1.16	69930	2.22468201	CS

IBO - Frequently Asked Questions (FAQ)

What is the current Impact Biomedical share price?

The current share price of Impact Biomedical is US$ 1.57

What is the 1 year trading range for Impact Biomedical share price?

Impact Biomedical has traded in the range of US$ 1.16 to US$ 3.25 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CHROChannel Therapeutics Corporation	US$ 1.31 (36.46%)	761.4k
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 12.9099 (13.84%)	40.07M
KOLDProShares UltraShort Bloomberg Natural Gas	US$ 31.50 (12.02%)	3.9M
RHERegional Health Properties Inc	US$ 2.26 (11.88%)	136.71k
RIOXDefiance Daily Target 2x Long Riot ETF	US$ 34.00 (10.80%)	216.29k
OSTXOS Therapies Incorporated	US$ 2.9529 (-28.33%)	1.01M
SCPXScorpius Holdings Inc	US$ 0.2828 (-24.99%)	1.12M
AEONAEON Biopharma Inc	US$ 0.1406 (-17.73%)	23.67M
FOXOFOXO Technologies Inc	US$ 0.26 (-17.46%)	6.78M
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 13.00 (-13.39%)	16.59M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 12.9095 (13.84%)	40.07M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 32.26 (7.57%)	40.04M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	US$ 18.46 (-7.38%)	35.18M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.0179 (-9.92%)	31.18M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.045 (-6.60%)	30.94M